Sign in to view content

Predictive Modeling of Proliferative Diabetic Retinopathy and DME Based on Analysis of High-Value Biomarkers

Kameran Lashkari, MD, FASRS

Video
Published 2019

Related

Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema: 36-Week Results From the Phase 2 BOULEVARD Clinical Trial
Rishi P. Singh, MD
Annual Meeting Talks
2018
Factors Predicting Vitreous Hemorrhage or Neovascularization after Pan-Retinal Photocoagulation in Proliferative Diabetic Retinopathy
Jose Davila, MD
Updates from the Field
2020
VISTA-DME Study Insights in Ellipsoid Zone Dynamics and Retinal Fluid Index
Ronald W Milam, MD
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more